Metastatic cancer patients more likely to survive at academic and high-volume hospitals when given immunotherapy: Study
A new study led by Yale Cancer Center researchers at Yale School of Medicine has revealed a significant increase in patients starting immunotherapy within one month of death. Using a national clinical database, the researchers ...
Jan 4, 2024
0
12